1. Home
  2. PEW vs ELTX Comparison

PEW vs ELTX Comparison

Compare PEW & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GrabAGun Digital Holdings Inc.

PEW

GrabAGun Digital Holdings Inc.

HOLD

Current Price

$2.31

Market Cap

72.6M

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$2.18

Market Cap

63.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PEW
ELTX
Founded
2007
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.6M
63.3M
IPO Year
2025
2014

Fundamental Metrics

Financial Performance
Metric
PEW
ELTX
Price
$2.31
$2.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$6.75
$18.00
AVG Volume (30 Days)
237.9K
266.2K
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
39.29
EPS
N/A
N/A
Revenue
$96,449,000.00
$2,301,000.00
Revenue This Year
$5.25
N/A
Revenue Next Year
$7.96
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.57
N/A
52 Week Low
$2.22
$2.34
52 Week High
$6.76
$16.00

Technical Indicators

Market Signals
Indicator
PEW
ELTX
Relative Strength Index (RSI) 38.81 24.01
Support Level $2.25 N/A
Resistance Level $2.75 $3.32
Average True Range (ATR) 0.08 0.13
MACD -0.01 -0.03
Stochastic Oscillator 24.37 1.09

Price Performance

Historical Comparison
PEW
ELTX

About PEW GrabAGun Digital Holdings Inc.

GrabAGun Digital Holdings Inc is a multi-brand eCommerce retailer of firearms, ammunition and related accessories. The Company's firearm products are ordered and paid for by customers online through the Company's eCommerce site and mobile app and are delivered to them on-premises through their choice of federal firearm licensed dealers nationwide. The Company's network of localized firearm dealers perform background checks on firearms purchasers and complete sales forms as mandated by federal and state firearm regulations.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

Share on Social Networks: